Peripheral neuropathy Board decisions

The Board remands the claims for service connection for diabetic peripheral neuropathy of both upper extremities due to an inadequate VA examination and opinion.

The Board granted an effective date of June 13, 2014, for the award of service connection for bilateral upper and lower extremity idiopathic peripheral neuropathy.

The Board denied the Veteran's claims for an initial disability rating in excess of 20 percent for service-connected fluoroquinolone-induced polyneuropathy of both lower extremities (sciatic nerve).

The Board granted service connection for various conditions, including emotional changes, weakness, difficulty concentrating, behavioral changes, cognitive impairment, decreased memory concentration and attention, memory loss, delayed reaction time, dizziness and vertigo, sleep disturbance, and difficulty hearing in noisy situations. The Veteran was also granted a 100 percent disability rating for residuals of traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD), as well as chronic fatigue syndrome.

The Board denied service connection for anxiety disorder, high blood pressure (hypertension), atherosclerotic heart disease, type II diabetes mellitus, and diabetic neuropathy of the bilateral upper and lower extremities. The effective date for service connection for bilateral hearing loss was also denied.

The Board granted service connection for right and left lower extremity neuropathy, as well as an effective date of August 21, 2020, for the award of service connection for a depressive disorder with generalized anxiety disorder and unspecified sleep-wake disorder.

The Board granted a total disability rating based on individual unemployability (TDIU) and awarded an earlier effective date for special monthly compensation based on loss of use of a creative organ, but denied other claims.

The Board granted service connection for fibromyalgia, peripheral neuropathy of all radicular groups of the bilateral upper extremities, and cervical strain with an effective date of July 17, 2021. The claim for migraines was remanded for further development.

The Board granted a 30 percent rating for right upper extremity peripheral neuropathy and a 20 percent rating for left upper extremity peripheral neuropathy, but denied an increased rating for degenerative arthritis of the lumbar spine.

The Board granted service connection for left lower extremity femoral neuropathy, right lower extremity femoral neuropathy, left lower extremity sciatic neuropathy, right lower extremity sciatic neuropathy, irritable bowel syndrome (IBS), and dermatitis. The claim for a rating in excess of 30 percent for posttraumatic stress disorder (PTSD) was denied.

The Board granted a 40 percent rating for left and right lower extremity diabetic peripheral neuropathy of the femoral and sciatic nerves, but denied higher ratings for left and right upper extremity diabetic PN.

The Board granted service connection for hypertension, peripheral neuropathy of the left and right lower extremities (secondary to hypertension), but denied service connection for Crohn's Disease.

The Board denied the Veteran's claim for service connection for peripheral neuropathy of the right lower extremity, finding that there was no evidence to support a causal relationship between the condition and the Veteran's active service or any service-connected disability.

The Board granted service connection for esophageal cancer, benign prostate hypertrophy, and erectile dysfunction secondary to the now service-connected benign prostate hypertrophy. The claims for larynx cancer, peripheral neuropathy of the upper and lower extremities, diabetes, an acquired psychiatric disorder, and a stomach disorder were denied.

The appeals for service connection for left and right lower extremity peripheral neuropathy, as well as sleep apnea, have been dismissed.

The Board granted service connection for right and left lower extremity peripheral neuropathy, to include as due to herbicide exposure.

The Board granted service connection for bilateral lower extremity peripheral neuropathy and higher initial ratings of 50 percent and 40 percent, respectively, for idiopathic peripheral neuropathy of the right and left median nerve.

The Board remands the claims for service connection for neuropathy in both lower extremities due to a pre-decisional duty to assist error, specifically regarding direct service connection.

The Board denied service connection for various conditions, including diabetes mellitus type II, low back disorder, and other musculoskeletal disorders, as well as a compensable rating for left ear hearing loss.

The Board denied service connection for type II diabetes, peripheral neuropathy of the bilateral upper and lower extremities, GERD, liver cancer, heart disability, skin cancer, sinusitis, and a heart disability on the basis that there was no evidence to support an in-service incurrence or continuity of symptomatology since service.